Neoadjuvant dual immuno-combination therapy with anti-LAG3 and anti-PD-1 antibodies is feasible and safe for resectable non-small cell lung cancer - EurekAlert!
New ACP guideline recommends combination therapy for acute episodic migraines - EurekAlert
New study shows combination therapy slows cognitive decline in at-risk populations
